9 Meters Biopharma Ownership 2024 | Who Owns 9 Meters Biopharma Now?


OverviewForecastChart

Institutional Ownership

0.00%

Insider Ownership

1.71%

Retail Ownership

98.29%

Institutional Holders

1.00

9 Meters Biopharma Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SABBY MANAGEMENT, LLC8.52%1.34%1,103,6451,103,645100.00%1,534,067,000Mar 31, 2023
SIMPLEX TRADING, LLC5.40%0.00%699,500-82,300-10.53%972,000Mar 31, 2023
ADAGE CAPITAL PARTNERS GP, L.L.C.5.02%0.00%650,000--903,500,000Mar 31, 2023
VANGUARD GROUP INC4.85%-628,306--873,345,000Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP3.72%0.00%482,300-29,300-5.73%670,397,000Mar 31, 2023
LAURION CAPITAL MANAGEMENT LP1.76%0.00%227,910--316,795,000Mar 31, 2023
BLACKROCK INC.1.30%-168,039-145-0.09%233,574,000Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC0.84%-108,824-1-0.00%151,265,000Mar 31, 2023
STATE STREET CORP0.39%-50,908--70,762,000Mar 31, 2023
ODONNELL FINANCIAL SERVICES, LLC0.34%0.11%43,410--60,340,000Mar 31, 2023
COMMONWEALTH EQUITY SERVICES, LLC0.29%0.00%37,885-256-0.67%52,000Mar 31, 2023
CIBC ASSET MANAGEMENT INC0.25%0.00%32,72232,722100.00%45,484,000Mar 31, 2023
CITADEL ADVISORS LLC0.20%-25,90013,730112.82%36,001,000Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.18%-23,500-1,000-4.08%32,665,000Mar 31, 2023
NORTHERN TRUST CORP0.17%-21,461-46-0.21%29,831,000Mar 31, 2023
HRT FINANCIAL LP0.14%0.00%18,249-24,281-57.09%25,000Mar 31, 2023
DIMENSIONAL FUND ADVISORS LP0.13%-16,264-255-1.54%22,607,000Mar 31, 2023
MILLENNIUM MANAGEMENT LLC0.12%-15,326-24,763-61.77%21,000Mar 31, 2023
REQUISITE CAPITAL MANAGEMENT, LLC0.12%0.01%15,00015,000100.00%20,850,000Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC0.11%-14,325-58,843-80.42%20,000Mar 31, 2023

9 Meters Biopharma's largest institutional shareholder is SABBY MANAGEMENT, LLC, holding 8.52% of the company's total share outstanding, currently valued at $1.53B. The top 10 institutional shareholders own together 32.13% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SABBY MANAGEMENT, LLC8.52%1.34%1,103,6451,103,645100.00%1,534,067,000Mar 31, 2023
ODONNELL FINANCIAL SERVICES, LLC0.34%0.11%43,410--60,340,000Mar 31, 2023
REQUISITE CAPITAL MANAGEMENT, LLC0.12%0.01%15,00015,000100.00%20,850,000Mar 31, 2023
LAURION CAPITAL MANAGEMENT LP1.76%0.00%227,910--316,795,000Mar 31, 2023
ADAGE CAPITAL PARTNERS GP, L.L.C.5.02%0.00%650,000--903,500,000Mar 31, 2023
SIMPLEX TRADING, LLC5.40%0.00%699,500-82,300-10.53%972,000Mar 31, 2023
HRT FINANCIAL LP0.14%0.00%18,249-24,281-57.09%25,000Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)0.04%0.00%5,0084,295602.38%7,000Mar 31, 2023
PSI ADVISORS, LLC0.00%0.00%300--417,000Mar 31, 2023
CIBC ASSET MANAGEMENT INC0.25%0.00%32,72232,722100.00%45,484,000Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP3.72%0.00%482,300-29,300-5.73%670,397,000Mar 31, 2023
REGISTER FINANCIAL ADVISORS LLC0.00%0.00%100--139,000Mar 31, 2023
COMMONWEALTH EQUITY SERVICES, LLC0.29%0.00%37,885-256-0.67%52,000Mar 31, 2023
STRATEGIC INVESTMENT SOLUTIONS, INC. /IL0.00%0.00%275275100.00%382,000Mar 31, 2023
HARTFORD FINANCIAL MANAGEMENT INC.0.00%0.00%200--278,000Mar 31, 2023
MERCER GLOBAL ADVISORS INC /ADV0.08%0.00%10,25010,250100.00%14,000Mar 31, 2023
BEACON CAPITAL MANAGEMENT, LLC0.00%0.00%155--215,000Mar 31, 2023
MCF ADVISORS LLC0.00%-275--383,000Mar 31, 2023
CERITY PARTNERS LLC0.08%-10,70810,708100.00%14,884,000Mar 31, 2023
GROUP ONE TRADING, L.P.0.04%-5,363-6,009-52.84%7,455,000Mar 31, 2023

The largest 9 Meters Biopharma shareholder by % of total assets is SABBY MANAGEMENT, LLC. The company owns 1.10M shares of 9 Meters Biopharma (NMTR), representing 1.34% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SABBY MANAGEMENT, LLC8.52%1.34%1,103,6451,103,645100.00%1,534,067,000Mar 31, 2023
CIBC ASSET MANAGEMENT INC0.25%0.00%32,72232,722100.00%45,484,000Mar 31, 2023
REQUISITE CAPITAL MANAGEMENT, LLC0.12%0.01%15,00015,000100.00%20,850,000Mar 31, 2023
CITADEL ADVISORS LLC0.20%-25,90013,730112.82%36,001,000Mar 31, 2023
CERITY PARTNERS LLC0.08%-10,70810,708100.00%14,884,000Mar 31, 2023
MERCER GLOBAL ADVISORS INC /ADV0.08%0.00%10,25010,250100.00%14,000Mar 31, 2023
CITADEL ADVISORS LLC0.09%-11,9008,735275.99%16,541,000Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)0.04%0.00%5,0084,295602.38%7,000Mar 31, 2023
STRATEGIC INVESTMENT SOLUTIONS, INC. /IL0.00%0.00%275275100.00%382,000Mar 31, 2023
BANK OF AMERICA CORP /DE/0.04%-5,7331352.41%7,969,000Mar 31, 2023
WELLS FARGO & COMPANY/MN0.00%-34020.59%473,000Mar 31, 2023
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO--2--3,000Mar 31, 2023
PNC FINANCIAL SERVICES GROUP, INC.0.00%-150--209,000Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.0.00%-600--833,000Mar 31, 2023
STATE STREET CORP0.39%-50,908--70,762,000Mar 31, 2023
TCI WEALTH ADVISORS, INC.0.00%-50--70,000Mar 31, 2023
VANGUARD GROUP INC4.85%-628,306--873,345,000Mar 31, 2023
STEWARD PARTNERS INVESTMENT ADVISORY, LLC0.01%-1,117--1,553,000Mar 31, 2023
MCF ADVISORS LLC0.00%-275--383,000Mar 31, 2023
BEACON CAPITAL MANAGEMENT, LLC0.00%0.00%155--215,000Mar 31, 2023

As of Mar 31 2023, 9 Meters Biopharma's largest institutional buyer is SABBY MANAGEMENT, LLC. The company purchased 1.10M stocks of NMTR, valued at $1.53B.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
GSA CAPITAL PARTNERS LLP----109,685-100.00%-Mar 31, 2023
SIMPLEX TRADING, LLC5.40%0.00%699,500-82,300-10.53%972,000Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC0.11%-14,325-58,843-80.42%20,000Mar 31, 2023
TWO SIGMA INVESTMENTS, LP----47,617-100.00%-Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP3.72%0.00%482,300-29,300-5.73%670,397,000Mar 31, 2023
HUDSON BAY CAPITAL MANAGEMENT LP----25,001-100.00%-Mar 31, 2023
MERIT FINANCIAL GROUP, LLC----25,000-100.00%-Mar 31, 2023
MILLENNIUM MANAGEMENT LLC0.12%-15,326-24,763-61.77%21,000Mar 31, 2023
HRT FINANCIAL LP0.14%0.00%18,249-24,281-57.09%25,000Mar 31, 2023
ADVISER INVESTMENTS LLC----21,429-100.00%-Mar 31, 2023
UBS GROUP AG0.03%-4,340-7,989-64.80%6,033,000Mar 31, 2023
GROUP ONE TRADING, L.P.0.04%-5,000-6,900-57.98%6,950,000Mar 31, 2023
GROUP ONE TRADING, L.P.0.04%-5,363-6,009-52.84%7,455,000Mar 31, 2023
SIMPLEX TRADING, LLC----1,500-100.00%-Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.18%-23,500-1,000-4.08%32,665,000Mar 31, 2023
ROCKEFELLER CAPITAL MANAGEMENT L.P.----1,000-100.00%-Mar 31, 2023
MORGAN STANLEY0.02%-2,582-572-18.14%3,589,000Mar 31, 2023
SABBY MANAGEMENT, LLC----543-100.00%-Mar 31, 2023
COMMONWEALTH EQUITY SERVICES, LLC0.29%0.00%37,885-256-0.67%52,000Mar 31, 2023
DIMENSIONAL FUND ADVISORS LP0.13%-16,264-255-1.54%22,607,000Mar 31, 2023

As of Mar 31 2023, 9 Meters Biopharma's biggest institutional seller is GSA CAPITAL PARTNERS LLP. The company sold -0.11M shares of NMTR, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SABBY MANAGEMENT, LLC8.52%1.34%1,103,6451,103,645100.00%1,534,067,000Mar 31, 2023
CIBC ASSET MANAGEMENT INC0.25%0.00%32,72232,722100.00%45,484,000Mar 31, 2023
REQUISITE CAPITAL MANAGEMENT, LLC0.12%0.01%15,00015,000100.00%20,850,000Mar 31, 2023
CERITY PARTNERS LLC0.08%-10,70810,708100.00%14,884,000Mar 31, 2023
MERCER GLOBAL ADVISORS INC /ADV0.08%0.00%10,25010,250100.00%14,000Mar 31, 2023
STRATEGIC INVESTMENT SOLUTIONS, INC. /IL0.00%0.00%275275100.00%382,000Mar 31, 2023

9 Meters Biopharma's largest new institutional shareholder by number of shares is SABBY MANAGEMENT, LLC, purchased 1.10M shares, valued at $1.53B, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
GSA CAPITAL PARTNERS LLP----109,685-100.00%-Mar 31, 2023
TWO SIGMA INVESTMENTS, LP----47,617-100.00%-Mar 31, 2023
HUDSON BAY CAPITAL MANAGEMENT LP----25,001-100.00%-Mar 31, 2023
MERIT FINANCIAL GROUP, LLC----25,000-100.00%-Mar 31, 2023
ADVISER INVESTMENTS LLC----21,429-100.00%-Mar 31, 2023
SIMPLEX TRADING, LLC----1,500-100.00%-Mar 31, 2023
ROCKEFELLER CAPITAL MANAGEMENT L.P.----1,000-100.00%-Mar 31, 2023
SABBY MANAGEMENT, LLC----543-100.00%-Mar 31, 2023
GROUP ONE TRADING, L.P.----100-100.00%-Mar 31, 2023

9 Meters Biopharma's largest sold out institutional shareholder by shares sold is GSA CAPITAL PARTNERS LLP, sold -0.11M shares, valued at -, as of undefined.

9 Meters Biopharma Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.07%32,519--Dec 31, 2023
QUANTITATIVE MASTER SERIES LLC0.05%312,482--Dec 31, 2023
TIAA SEPARATE ACCOUNT VA 10.03%6,325--Dec 31, 2023
VANGUARD INDEX FUNDS0.03%12,131,400--Dec 31, 2023
VANGUARD VALLEY FORGE FUNDS0.02%8,477--Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.01%2,013,233--Feb 29, 2024
Calvert Variable Products, Inc.0.01%16,663--Dec 31, 2023
VANGUARD VARIABLE INSURANCE FUNDS0.01%318,323--Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS0.01%175,410--Dec 31, 2023
Chartwell Funds0.00%86,748--Jun 30, 2022
SCHWAB CAPITAL TRUST0.00%107,754--Feb 29, 2024
Voya VARIABLE PORTFOLIOS INC0.00%80,326--Dec 31, 2023
Principal Exchange-Traded Funds0.00%28,865--Mar 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%7,734--Dec 31, 2023
TIAA-CREF LIFE FUNDS0.00%4,288--Dec 31, 2023
VANGUARD INDEX FUNDS0.00%606,825--Dec 31, 2023
COLLEGE RETIREMENT EQUITIES FUND0.00%1,517,720--Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND II0.00%11,939--Dec 31, 2023
FIDELITY SALEM STREET TRUST0.00%1,615,070--Feb 29, 2024
T. Rowe Price Index Trust, Inc.0.00%9,555--Feb 29, 2024
ProFunds0.00%4,842--Jan 31, 2024
RYDEX SERIES FUNDS0.00%2,157--Dec 31, 2023
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%44,200--Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%99,321--Feb 29, 2024
EQ ADVISORS TRUST0.00%511,366--Dec 31, 2023
VANGUARD SCOTTSDALE FUNDS0.00%772,642--Feb 29, 2024
FLEXSHARES TRUST0.00%29,516--Jan 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%8,771--Dec 31, 2023
RYDEX DYNAMIC FUNDS0.00%1,194--Dec 31, 2023
PENN SERIES FUNDS INC0.00%8,200--Dec 29, 2023
VALIC Co I0.00%83,918--Feb 29, 2024
Guggenheim Active Allocation Fund0.00%1,334--Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%28,347--Dec 31, 2023
RYDEX VARIABLE TRUST0.00%215--Dec 31, 2023
NATIONWIDE MUTUAL FUNDS0.00%21,694--Jan 31, 2024
PROSHARES TRUST0.00%32,637--Feb 29, 2024
NORTHERN FUNDS0.00%115,184--Dec 29, 2023
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%188,600--Dec 31, 2023
MORGAN STANLEY PATHWAY FUNDS0.00%8,548--Feb 29, 2024
SUNAMERICA SERIES TRUST0.00%24,965--Jan 31, 2024
Brighthouse Funds Trust II0.00%84,767--Dec 31, 2023
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%59,697--Dec 31, 2023
Dimensional ETF Trust0.00%11,364--Jan 31, 2024
PACIFIC SELECT FUND0.00%74,035--Dec 31, 2023
MASSMUTUAL SELECT FUNDS0.00%19,815--Dec 31, 2023
iSHARES TRUST0.00%106,503--Feb 29, 2024
BlackRock Variable Series Funds, Inc.0.00%25,349--Dec 31, 2023
PRINCIPAL FUNDS, INC.0.00%33,923--Feb 29, 2024
Bridge Builder Trust0.00%29,996--Dec 31, 2023
BLACKROCK FUNDS0.00%29,422--Feb 29, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%45,400--Feb 29, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%1,830--Jan 31, 2024
John Hancock Funds II0.00%26,293--Feb 29, 2024
iSHARES TRUST0.00%4,851--Feb 29, 2024
Meeder Funds0.00%1--Mar 31, 2024
AQR Funds0.00%108,293--Dec 31, 2023

9 Meters Biopharma's largest mutual fund holder by % of total assets is "DEUTSCHE DWS INVESTMENTS VIT FUNDS", owning 32.52K shares, compromising 0.07% of its total assets.

9 Meters Biopharma Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Dec, 221-98.46%
30 Sep, 2265-16.67%
30 Jun, 2278-16.13%
31 Mar, 2293-9.71%
31 Dec, 21103-0.96%
30 Sep, 211046.12%
30 Jun, 219815.29%
31 Mar, 218551.79%
31 Dec, 205636.59%
30 Sep, 204157.69%
30 Jun, 2026-

As of 31 Dec 22, 1 institutions are holding 9 Meters Biopharma's shares, representing a decrease of -98.46% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Dec, 22101-100.00%
30 Sep, 2247,980,588-17.12%
30 Jun, 2257,890,161-23.03%
31 Mar, 2275,215,770-4.14%
31 Dec, 2178,461,2298.32%
30 Sep, 2172,431,860-1.91%
30 Jun, 2173,845,6110.97%
31 Mar, 2173,139,80320.44%
31 Dec, 2060,727,489103.03%
30 Sep, 2029,910,2394.46%
30 Jun, 2028,633,597-

9 Meters Biopharma (NMTR) has 101.00 shares outstanding as of 31 Dec 22, down -100.00% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Dec, 220.00%-
30 Sep, 22370.35%0.19%
30 Jun, 22447.02%0.13%
31 Mar, 22582.54%0.15%
31 Dec, 21617.11%0.19%
30 Sep, 21569.69%0.16%
30 Jun, 21591.82%0.12%
31 Mar, 21692.35%0.09%
31 Dec, 20857.58%0.48%
30 Sep, 20422.38%0.08%
30 Jun, 20728.73%-

As of 31 Dec 22, 9 Meters Biopharma is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 30 Sep 22.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Dec, 221-96.43%
30 Sep, 2228-20.00%
30 Jun, 223529.63%
31 Mar, 2227-37.21%
31 Dec, 2143-6.52%
30 Sep, 2146-24.59%
30 Jun, 2161-
31 Mar, 216164.86%
31 Dec, 20372.78%
30 Sep, 203644.00%
30 Jun, 2025-

1 institutional shareholders have increased their position in NMTR stock as of 31 Dec 22 compared to 28 in the previous quarter (a -96.43% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Dec, 22--100.00%
30 Sep, 22166.67%
30 Jun, 2215-51.61%
31 Mar, 223114.81%
31 Dec, 212742.11%
30 Sep, 211935.71%
30 Jun, 211427.27%
31 Mar, 2111120.00%
31 Dec, 205400.00%
30 Sep, 201-
30 Jun, 20--

- institutional shareholders have reduced their position in NMTR stock as of 31 Dec 22 compared to 16 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Dec, 221-98.46%101-100.00%0.00%-1-96.43%--100.00%
30 Sep, 2265-16.67%47,980,588-17.12%370.35%0.19%28-20.00%166.67%
30 Jun, 2278-16.13%57,890,161-23.03%447.02%0.13%3529.63%15-51.61%
31 Mar, 2293-9.71%75,215,770-4.14%582.54%0.15%27-37.21%3114.81%
31 Dec, 21103-0.96%78,461,2298.32%617.11%0.19%43-6.52%2742.11%
30 Sep, 211046.12%72,431,860-1.91%569.69%0.16%46-24.59%1935.71%
30 Jun, 219815.29%73,845,6110.97%591.82%0.12%61-1427.27%
31 Mar, 218551.79%73,139,80320.44%692.35%0.09%6164.86%11120.00%
31 Dec, 205636.59%60,727,489103.03%857.58%0.48%372.78%5400.00%
30 Sep, 204157.69%29,910,2394.46%422.38%0.08%3644.00%1-
30 Jun, 2026-28,633,597-728.73%-25---

9 Meters Biopharma Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 21, 2023Sensenig Bethanyofficer Chief Financial OfficerS-SaleSell9,100$1.21$11.01K41,077
Jul 08, 2022Temperato Johnofficer Chief Executive OfficerP-PurchaseBuy125,000$0.23$28.46K1,427,522
Jul 06, 2022Sirgo Mark Adirector P-PurchaseBuy175,000$0.25$42.96K1,454,044
May 24, 2022Constantino Michael T.director P-PurchaseBuy16,000$0.48$7.61K60,508

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 08, 2022Temperato Johnofficer Chief Executive OfficerP-PurchaseBuy125,000$0.23$28.46K1,427,522
Jul 06, 2022Sirgo Mark Adirector P-PurchaseBuy175,000$0.25$42.96K1,454,044
May 24, 2022Constantino Michael T.director P-PurchaseBuy16,000$0.48$7.61K60,508

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 21, 2023Sensenig Bethanyofficer Chief Financial OfficerS-SaleSell9,100$1.21$11.01K41,077

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 21, 2023Sensenig Bethanyofficer Chief Financial OfficerS-SaleSell9,100$1.21$11.01K41,077
Mar 31, 2023Sirgo Mark Adirector-A-AwardBuy7,885--85,907
Mar 31, 2023RICE YEHUDA MICHAELdirector-A-AwardBuy7,885--7,885
Mar 31, 2023JOHNSON LORIN Kdirector-A-AwardBuy7,885--12,125
Mar 31, 2023Constantino Michael T.director-A-AwardBuy7,885--10,911
Mar 31, 2023Ventimiglia Samanthadirector-A-AwardBuy7,885--7,885
Mar 29, 2023Sensenig Bethanyofficer Chief Financial OfficerA-AwardBuy50,177--50,177
Mar 29, 2023Temperato Johndirector, officer Chief Executive OfficerA-AwardBuy68,815--140,192
Jul 22, 2022Sirgo Mark Adirector-A-AwardBuy175,000$0.25$42.96K1,560,427
Jul 08, 2022Temperato Johnofficer Chief Executive OfficerP-PurchaseBuy125,000$0.23$28.46K1,427,522
Jul 06, 2022Sirgo Mark Adirector P-PurchaseBuy175,000$0.25$42.96K1,454,044
Jun 23, 2022Sirgo Mark Adirector A-AwardBuy142,509--142,509
Jun 23, 2022Sirgo Mark Adirector-A-AwardBuy142,509$0.26$37.75K142,509
Jun 23, 2022Ventimiglia Samanthadirector A-AwardBuy142,509--142,509
Jun 23, 2022RICE YEHUDA MICHAELdirector A-AwardBuy142,509--142,509
Jun 23, 2022RICE YEHUDA MICHAELdirector-A-AwardBuy142,509$0.26$37.75K142,509
Jun 23, 2022JOHNSON LORIN Kdirector A-AwardBuy142,509--142,509
Jun 23, 2022JOHNSON LORIN Kdirector-A-AwardBuy142,509$0.26$37.75K142,509
Jun 23, 2022Constantino Michael T.director A-AwardBuy142,509--142,509
May 24, 2022Constantino Michael T.director P-PurchaseBuy16,000$0.48$7.61K60,508

The last insider sell of 9 Meters Biopharma's stock was made by Sensenig Bethany on Apr 21 2023, selling 9,100 shares at $1.21 per share (valued at $11.01K). The last insider buy of NMTR was made by Temperato John on Jul 08 2022, buying 125,000 shares at $0.23 per share (worth $28.46K).

9 Meters Biopharma Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2023-1-
Q1 20237--
Q3 20223--
Q2 20228--
Q1 20224--
Q4 20214--
Q3 20215--
Q2 2021103333.33%
Q1 20213--
Q4 2020102500.00%
Q3 202017--
Q2 2020389422.22%
Q3 20193--
Q2 201910--
Q4 201813--
Q3 201817--
Q2 2018---
Q1 20185955.56%
Q4 20175--
Q3 20173--

0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by 9 Meters Biopharma's insiders, as of Q2 2023.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2023-1-
Q1 2023---
Q3 20222--
Q2 20223--
Q1 20222--
Q4 20213--
Q3 20215--
Q2 202133100.00%
Q1 2021---
Q4 20203--
Q3 20208--
Q2 202017--
Q3 2019---
Q2 20196--
Q4 20187--
Q3 201817--
Q2 2018---
Q1 20181--
Q4 20171--
Q3 2017---

As of Q2 2023, Insider owners conducted 0 open market buy trades and 1 open market sell trades of 9 Meters Biopharma's stocks.

9 Meters Biopharma Peer Ownership


TickerCompany
KAKineta, Inc.
ABOSAcumen Pharmaceuticals, Inc.
TPSTTempest Therapeutics, Inc.
GRTXGalera Therapeutics, Inc.
CRISCuris, Inc.
HSTOHistogen Inc.
MREOMereo BioPharma Group plc
ALRNAileron Therapeutics, Inc.
MGTADianthus Therapeutics, Inc.
ARTLArtelo Biosciences, Inc.
INKTMiNK Therapeutics, Inc.
RNXTRenovoRx, Inc.
INZYInozyme Pharma, Inc.
VINCVincerx Pharma, Inc.
CADLCandel Therapeutics, Inc.
DAWNDay One Biopharmaceuticals, Inc.
ALVRAlloVir, Inc.
MEIPMEI Pharma, Inc.
IKNAIkena Oncology, Inc.
FBRXForte Biosciences, Inc.
ATXIAvenue Therapeutics, Inc.
KZRKezar Life Sciences, Inc.
CBIOGyre Therapeutics, Inc.

NMTR Ownership FAQ


9 Meters Biopharma is owned by institutional shareholders (0.00%), insiders (1.71%), and public (98.29%). The largest institutional shareholder of 9 Meters Biopharma is SABBY MANAGEMENT, LLC (8.52% of total shares) and the top mutual fund owner is DEUTSCHE DWS INVESTMENTS VIT FUNDS (0.07% of total shares).

9 Meters Biopharma's major institutional shareholders are SABBY MANAGEMENT, LLC, SIMPLEX TRADING, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP. The top five shareholders own together 27.51% of the company's share outstanding.

As of Dec 2022, there are 1 institutional shareholders of 9 Meters Biopharma.

SABBY MANAGEMENT, LLC owns 1.1M shares of 9 Meters Biopharma, representing 8.52% of the company's total shares outstanding, valued at $1.53B (as of Mar 2023).

As of Mar 2023, SIMPLEX TRADING, LLC holds 699.5K shares of 9 Meters Biopharma (NMTR), compromising 5.40% of the company, valued at $972K.

ADAGE CAPITAL PARTNERS GP, L.L.C is the third largest holder of 9 Meters Biopharma. The company owns 650K of the company's shares outstanding (worth $903.5M).